Related Experiment Video
Updated: Jul 28, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Exchange transfusion in severe infant salicylism
Adriana Manikian1, Susan Stone, Richard Hamilton
1Department of Pediatrics, New York University School of Medicine, NY 10016, USA.
Veterinary and Human Toxicology
|July 26, 2002
Summary
Exchange transfusion effectively removed salicylate (ASA) in an infant with severe poisoning when hemodialysis was not feasible. This procedure safely treated the infant, offering a viable alternative for salicylate toxicity management in infants.
Area of Science:
- Pediatric Toxicology
- Emergency Medicine
- Cardiovascular Procedures
Background:
- Severe salicylate poisoning in infants presents a critical management challenge.
- Hemodialysis is often the preferred treatment but may be precluded by patient size.
- Alternative methods for toxin removal are crucial in pediatric cases.
Observation:
- An infant with severe salicylate poisoning (ASA level 85 mg/dL) deteriorated despite standard treatments.
- Hemodialysis was not feasible due to the infant's small size.
- Exchange transfusion was performed using packed red blood cells and fresh frozen plasma.
Findings:
- Exchange transfusion significantly reduced salicylate levels from 70.1 mg/dL to 34.4 mg/dL immediately post-procedure.
- Salicylate levels continued to decrease post-procedure, reaching < 2 mg/dL by 48 hours.
- The procedure was performed without complications, and the infant recovered fully.
Implications:
- Double volume exchange transfusion is a safe and effective alternative to hemodialysis for severe infant salicylate poisoning.
- This approach expands treatment options for pediatric toxicological emergencies.
- Highlights the importance of considering exchange transfusion in specific pediatric poisoning scenarios.
